UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...

As the second leading cause of death globally, cancer is a worldwide health crisis, particularly as life expectancies continue to increase. In its final stages, cancer spreads throughout the body in a ...

A newly discovered gene switch may help turn chemotherapy-resistant pancreatic cancer into a treatable disease.

Liver cancer, particularly hepatocellular carcinoma (HCC), presents major clinical challenges due to the multifaceted nature of its tumor immune ...

Scientists at Georgetown University's Lombardi Comprehensive Cancer Center have uncovered a new dual function for a ...

Molecular glues are small, monovalent molecules that reshape an E3 ubiquitin ligase (E3) surface to promote a new protein-protein interaction with a target, triggering ubiquitination and removal by ...

A Ghanaian Scientist’s breakthrough research on fluorescent molecular probes could transform how the world detects cancer at ...

Durability of Response With Selpercatinib in Patients With RET-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001 The question of whether to change tumor naming is a very ...

Explore how paclitaxel and innovative drug delivery systems are changing cancer treatment and improving therapeutic outcomes.

Mythreye Karthikeyan, Ph.D., an associate professor in the Division of Molecular and Cellular Pathology, has been appointed Co-Leader of the UAB O'Neal Comprehensive Cancer Center's Cancer Biology and ...